Ribo-seq suggests a translational upregulation of Ybx1 during cardiac hypertrophy, while Ybx1 mRNA levels remain virtually unchanged according to RNA-seq (Fig. 1C, D). The gene discussed is YBX1; the disease is cardiac hypertrophy.